These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 22912397)

  • 1. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
    Mas E; Croft KD; Zahra P; Barden A; Mori TA
    Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered SPMs and age-associated decrease in brain DHA in
    Martinsen A; Tejera N; Vauzour D; Harden G; Dick J; Shinde S; Barden A; Mori TA; Minihane AM
    FASEB J; 2019 Sep; 33(9):10315-10326. PubMed ID: 31251078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.
    Serhan CN; Gotlinger K; Hong S; Lu Y; Siegelman J; Baer T; Yang R; Colgan SP; Petasis NA
    J Immunol; 2006 Feb; 176(3):1848-59. PubMed ID: 16424216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.
    Perry SC; Kalyanaraman C; Tourdot BE; Conrad WS; Akinkugbe O; Freedman JC; Holinstat M; Jacobson MP; Holman TR
    J Lipid Res; 2020 Jul; 61(7):1087-1103. PubMed ID: 32404334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
    See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
    Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.
    Clària J; Dalli J; Yacoubian S; Gao F; Serhan CN
    J Immunol; 2012 Sep; 189(5):2597-605. PubMed ID: 22844113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.
    Serhan CN; Yang R; Martinod K; Kasuga K; Pillai PS; Porter TF; Oh SF; Spite M
    J Exp Med; 2009 Jan; 206(1):15-23. PubMed ID: 19103881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.
    Sun YP; Oh SF; Uddin J; Yang R; Gotlinger K; Campbell E; Colgan SP; Petasis NA; Serhan CN
    J Biol Chem; 2007 Mar; 282(13):9323-9334. PubMed ID: 17244615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.
    Mas E; Barden A; Burke V; Beilin LJ; Watts GF; Huang RC; Puddey IB; Irish AB; Mori TA
    Clin Nutr; 2016 Apr; 35(2):331-336. PubMed ID: 25908532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6).
    Dangi B; Obeng M; Nauroth JM; Chung G; Bailey-Hall E; Hallenbeck T; Arterburn LM
    Biochem Pharmacol; 2010 Jan; 79(2):251-60. PubMed ID: 19679107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
    Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of chemoresistance-inducing fatty acid in food supplements using UHPLC-ESI-MS/MS.
    Schlotterbeck J; Cebo M; Kolb A; Lämmerhofer M
    Anal Bioanal Chem; 2019 Jan; 411(2):479-491. PubMed ID: 30460390
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Tsai WC; Kalyanaraman C; Yamaguchi A; Holinstat M; Jacobson MP; Holman TR
    Biochemistry; 2021 Jun; 60(22):1741-1754. PubMed ID: 34029049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways.
    Dalli J; Ramon S; Norris PC; Colas RA; Serhan CN
    FASEB J; 2015 May; 29(5):2120-36. PubMed ID: 25713027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Complete Stereochemical Assignments of the New Resolvin Conjugates in Tissue Regeneration in Human Tissues that Stimulate Proresolving Phagocyte Functions and Tissue Regeneration.
    de la Rosa X; Norris PC; Chiang N; Rodriguez AR; Spur BW; Serhan CN
    Am J Pathol; 2018 Apr; 188(4):950-966. PubMed ID: 29571326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
    See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of sickle cell disease-associated inflammation and tissue damage with 17
    Matte A; Recchiuti A; Federti E; Koehl B; Mintz T; El Nemer W; Tharaux PL; Brousse V; Andolfo I; Lamolinara A; Weinberg O; Siciliano A; Norris PC; Riley IR; Iolascon A; Serhan CN; Brugnara C; De Franceschi L
    Blood; 2019 Jan; 133(3):252-265. PubMed ID: 30404812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta.
    Jones ML; Mark PJ; Keelan JA; Barden A; Mas E; Mori TA; Waddell BJ
    J Lipid Res; 2013 Aug; 54(8):2247-2254. PubMed ID: 23723388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
    Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
    Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
    Barden AE; Mas E; Croft KD; Phillips M; Mori TA
    Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.